University of Oklahoma

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Oklahoma sits in the top decile of US sponsors by registered trial count (#100 of 15,742 sponsors by registered trial count).

358 total trials 80 currently recruiting 196 completed early-phase tilt top decile by trial count

University of Oklahoma: 358 sponsored US clinical trials, 80 recruiting.

University of Oklahoma sponsors 358 registered US clinical trials on ClinicalTrials.gov, 80 of them currently recruiting, and 196 completed. 26 of these trials are in Phase 3-4 (later-stage) and 88 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 6 trials.

Top-decile sponsor footprint

University of Oklahoma ranks in the top decile of sponsors by registered trial count (#100 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 44/100

196 of 240 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

358 total, page 4 of 8

COMPLETED NA

The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections

NCT05615805
COMPLETED Early Phase 1

Caffeine and Cerebrovascular Reactivity

NCT04730193
COMPLETED Phase 4

Comparing the Effects of Different Doses of Dexamethasone to Treat Inpatient COVID-19

NCT04707534
COMPLETED NA

Diabetes Smoking Cessation Incentives Study

NCT04682067
COMPLETED Early Phase 1

Towards Enhanced Recovery After Cesarean

NCT04612920
TERMINATED NA

Automated Mobile Contingency Management for Smoking Cessation: A Pilot RCT (SCC PREVAILgo)

NCT03739437
COMPLETED NA

Neonatal Warming to Prevent Hypothermia

NCT04827394
COMPLETED NA

Suturing Techniques on Perineal Pain

NCT05264194
COMPLETED NA

Cognitive-Behavioral Therapy for Children With Nightmares as a Mediator of Suicide Risk (COMAA)

NCT05588739
COMPLETED NA

Community-engaged Approaches to Testing in Community and Healthcare Settings for Underserved Populations

NCT04870307
COMPLETED NA

High Flow Nasal Cannula With Noninvasive Ventilation

NCT04507425
COMPLETED Early Phase 1

Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents

NCT04523246
COMPLETED NA

Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice

NCT04454723
COMPLETED NA

Perceptions of Cigarette Smoking in Young Adults

NCT03953508
COMPLETED NA

Project Persist: mHealth for Cancer Survivorship

NCT04126642
COMPLETED NA

A Feasibility Study for the Use of Multispectral Optoacoustic Tomography in the Detection of Tumors

NCT04365413
COMPLETED NA

Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients

NCT04397614
TERMINATED NA

Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma

NCT04341740
COMPLETED NA

Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment

NCT04416919
TERMINATED NA

Neuromodulation of Inflammation and Vascular Function in Systolic Heart Failure

NCT03945058
TERMINATED Phase 2

Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO)

NCT03722966
COMPLETED Early Phase 1

Immediate Postpartum Insertion of Contraceptive Intrauterine Devices

NCT03657602
COMPLETED NA

Vagus Nerve Stimulation in Treatment of Postural Orthostatic Tachycardia Syndrome

NCT03930914
COMPLETED NA

Virtual Technical Assistance for Child and Adult Care Food Program in Family Child Care Home

NCT04345874
COMPLETED Phase 2

Smartphone Based Smoking Cessation Intervention

NCT03740490
COMPLETED

Functional Intermuscular Reduction of Spasticity

NCT04403594
COMPLETED NA

The Produce Drop: Using Food as Medicine to Lower A1C Levels and Blood Pressure

NCT04421755
COMPLETED NA

Renal Effects of Melatonin Trial in Chronic Kidney Disease

NCT04336566
COMPLETED NA

Physical Activity for People With Behavioral Diagnoses

NCT05041634
COMPLETED NA

The Effect of Punctal Plugs on Ocular Surface After Povidone-Iodine Preparation of Intravitreal Injection

NCT03945071
COMPLETED Phase 1

Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer

NCT03892642
TERMINATED Early Phase 1

Dual Versus Single Shock for Cardioversion of Atrial Fibrillation

NCT03943693
COMPLETED NA

Cognitive Behavioral Therapy for Nightmares in Children

NCT04047277
COMPLETED NA

Recruitment Messages for Current Smokers Recently Diagnosed With Cancer

NCT05471284
COMPLETED NA

UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery

NCT03898310
COMPLETED

Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma

NCT04205708
COMPLETED Early Phase 1

Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term

NCT03801252
COMPLETED NA

Screening for Atrial Fibrillation in Native AmeRicans Using iPhone ECG

NCT03740477
COMPLETED

Baby Albert: Electronic Cigarette Pharmacokinetics (PK) and Abuse Liability

NCT03637452
COMPLETED NA

Project Phoenix: Pilot Intervention for Smokers Who Are Not Ready to Quit Smoking

NCT03405129
COMPLETED NA

Volumetric Changes and Graft Stability in Lateral Window Sinus Augmentation: A Prospective Clinical Trial

NCT03639077
COMPLETED NA

Low-Level EMF Stimulation for Paroxysmal Atrial Fibrillation

NCT03593486
COMPLETED NA

Mobile Contingency Management for Smoking Cessation (R01 Supplement) (PrevailGO)

NCT03517397
COMPLETED NA

Sacrocolpopexy With Posterior Repair Obstructed Defecation Symptoms

NCT03658395
COMPLETED Phase 2

Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium

NCT03476798
COMPLETED NA

Incentivized Smoking Cessation for Diabetics

NCT03527667
COMPLETED NA

The Effect of Low LEVel TrAgus STimulation on the Electrophysiological Substrate of Patients With Ischemic CardioMyopathy Substrate of Subjects With Ischemic CardioMyopathy

NCT03549468
TERMINATED NA

The Effects of a Low Carbohydrate, Non-Ketogenic Diet Versus Standard Diabetes Diet on Glycemic Control in Type 1 Diabetes

NCT03544892
COMPLETED Phase 3

Homeless Care Management App

NCT03399500
COMPLETED NA

Neuromodulation to Treat Patients With Heart Failure With Preserved Ejection Fraction

NCT03327649
← Previous Page 4 of 8 Next →

Phase Distribution

PhaseTrial count
Phase 1 48
Phase 2 40
Phase 3 8
Phase 4 18

Therapeutic Areas

Prostate Cancer 6
Smoking Cessation 5
Health Behavior 4
Peripheral Artery Disease 4
Substance Use Disorders 4
Claudication 3
Cigarette Smoking 3
Tobacco Use 3
Atrial Fibrillation 3
Endometrial Cancer 3

What is open in the University of Oklahoma pipeline

80 recruiting of 358 indexed (22% open); 196 completed (55%).

Phase mix: 26 late (III/IV) vs 88 early (I/II) (early-phase heavy).

Top condition: Prostate Cancer (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Oklahoma: open-pipeline peers nationwide

Peers matched on 358 registered trials and 22% open enrollment, not the therapeutic-area sidebar.

University of Oklahoma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400 0%5%10%15%20%25% Total trials Recruiting share University of OklahomaNew York State Psychiatric InstituteRoswell Park Cancer InstituteUNC Lineberger Comprehensive Cancer CenterUniversity of ArizonaALX OncologyBiosense WebsterEnglewood Hospital and Medical CenterEnsysce Biosciences
University of Oklahoma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Oklahoma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 358 trials (± recruiting share)

Sponsors near 22% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Oklahoma page

358 registered trials is a research-attention snapshot, not an endorsement of University of Oklahoma or any single study.

  • 80 of University of Oklahoma's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Prostate Cancer is the condition University of Oklahoma studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Oklahoma pipeline card: 358 registered trials from official public datasets.Report a data error.